Synaptogenix, Inc.
SNPX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.01 | 0.02 | 0.04 |
| FCF Yield | -114.09% | -163.31% | -141.70% | -20.48% |
| EV / EBITDA | 1.05 | 3.07 | 1.83 | -0.66 |
| Quality | ||||
| ROIC | -40.74% | -30.98% | -70.68% | -37.63% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.38 | 0.86 | 2.01 | 0.69 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | 5.64% | 53.86% | -28.74% | -7.48% |
| Safety | ||||
| Net Debt / EBITDA | 1.38 | 3.45 | 2.32 | 2.71 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -20,754.44 | -25,569.73 | -42,172.77 | -95,292.93 |